Immune-related adverse event-associated sclerosing cholangitis (irAE-SC) is a rare and often steroid-refractory biliary complication for which optimal treatment has not been established. A 54-year-old woman undergoing pembrolizumab-based chemotherapy for recur... ...

请注册登录后继续浏览